Detalhe da pesquisa
1.
A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease.
J Autoimmun
; 95: 1-14, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30446251
2.
Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells.
J Autoimmun
; 56: 66-80, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25457307
3.
Characterization of anti-drug antibody responses to the T-cell engaging bispecific antibody cibisatamab to understand the impact on exposure.
Front Immunol
; 15: 1406353, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38881900
4.
Costimulation blockade in combination with IL-2 permits regulatory T cell sparing immunomodulation that inhibits autoimmunity.
Nat Commun
; 13(1): 6757, 2022 11 09.
Artigo
Inglês
| MEDLINE | ID: mdl-36347877
5.
Simlukafusp alfa (FAP-IL2v) immunocytokine is a versatile combination partner for cancer immunotherapy.
MAbs
; 13(1): 1913791, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33974508
6.
Kinetic screening of antibody-Im7 conjugates by capture on a colicin E7 DNase domain using optical biosensors.
Anal Biochem
; 385(2): 346-57, 2009 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-19073134
7.
Excystation of Eimeria tenella sporozoites impaired by antibody recognizing gametocyte/oocyst antigens GAM22 and GAM56.
Eukaryot Cell
; 7(2): 202-11, 2008 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-18083827
8.
Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy.
Sci Transl Med
; 11(496)2019 06 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31189721
9.
Author Correction: Costimulation blockade in combination with IL-2 permits regulatory T cell sparing immunomodulation that inhibits autoimmunity.
Nat Commun
; 14(1): 5724, 2023 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37714833
10.
In vitro display technologies reveal novel biopharmaceutics.
FASEB J
; 20(10): 1599-610, 2006 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-16873883
11.
Selection of human anti-CD28 scFvs from a T-NHL related scFv library using ribosome display.
J Biotechnol
; 130(4): 448-54, 2007 Jul 15.
Artigo
Inglês
| MEDLINE | ID: mdl-17604868
12.
Target Expression, Generation, Preclinical Activity, and Pharmacokinetics of the BCMA-T Cell Bispecific Antibody EM801 for Multiple Myeloma Treatment.
Cancer Cell
; 31(3): 396-410, 2017 03 13.
Artigo
Inglês
| MEDLINE | ID: mdl-28262554
13.
A new generation of protein display scaffolds for molecular recognition.
Protein Sci
; 15(1): 14-27, 2006 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-16373474
14.
XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and enhanced immune activation for the treatment of pancreatic cancer.
MAbs
; 8(4): 811-27, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-26984378
15.
A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors.
Clin Cancer Res
; 22(13): 3286-97, 2016 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26861458
16.
RG7386, a Novel Tetravalent FAP-DR5 Antibody, Effectively Triggers FAP-Dependent, Avidity-Driven DR5 Hyperclustering and Tumor Cell Apoptosis.
Mol Cancer Ther
; 15(5): 946-57, 2016 05.
Artigo
Inglês
| MEDLINE | ID: mdl-27037412
17.
Immuno-PET and Immuno-SPECT of Rheumatoid Arthritis with Radiolabeled Anti-Fibroblast Activation Protein Antibody Correlates with Severity of Arthritis.
J Nucl Med
; 56(5): 778-83, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25858044
18.
Eimeria tenella: genomic organization and expression of an 89kDa cyclophilin.
Exp Parasitol
; 118(2): 275-9, 2008 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-17892870
19.
Ribosome display for improved biotherapeutic molecules.
Expert Opin Biol Ther
; 6(2): 177-87, 2006 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-16436043